These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14500731)

  • 1. Distortion of the catalytic domain of tissue-type plasminogen activator by plasminogen activator inhibitor-1 coincides with the formation of stable serpin-proteinase complexes.
    Perron MJ; Blouse GE; Shore JD
    J Biol Chem; 2003 Nov; 278(48):48197-203. PubMed ID: 14500731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.
    Olson ST; Swanson R; Day D; Verhamme I; Kvassman J; Shore JD
    Biochemistry; 2001 Oct; 40(39):11742-56. PubMed ID: 11570875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism.
    Egelund R; Petersen TE; Andreasen PA
    Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A concerted structural transition in the plasminogen activator inhibitor-1 mechanism of inhibition.
    Blouse GE; Perron MJ; Thompson JH; Day DE; Link CA; Shore JD
    Biochemistry; 2002 Oct; 41(40):11997-2009. PubMed ID: 12356300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases.
    Aertgeerts K; De Ranter CJ; Booth NA; Declerck PJ
    J Struct Biol; 1997 Apr; 118(3):236-42. PubMed ID: 9169233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor type-1 interacts exclusively with the proteinase domain of tissue plasminogen activator.
    Björquist P; Brohlin M; Ehnebom J; Ericsson M; Kristiansen C; Pohl G; Deinum J
    Biochim Biophys Acta; 1994 Dec; 1209(2):191-202. PubMed ID: 7811690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1.
    Gong L; Liu M; Zeng T; Shi X; Yuan C; Andreasen PA; Huang M
    J Biol Chem; 2015 Oct; 290(43):25795-804. PubMed ID: 26324706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 19F NMR studies of plasminogen activator inhibitor-1.
    Abbott GL; Blouse GE; Perron MJ; Shore JD; Luck LA; Szabo AG
    Biochemistry; 2004 Feb; 43(6):1507-19. PubMed ID: 14769027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of the complex of plasminogen activator inhibitor type 1 with tissue-type plasminogen activator by mass spectrometry and size-exclusion chromatography.
    Strömqvist M; Karlsson KE; Björquist P; Andersson JO; Byström M; Hansson L; Johansson T; Deinum J
    Biochim Biophys Acta; 1996 Jun; 1295(1):103-9. PubMed ID: 8679667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants in the stability of the serpin/proteinase complex.
    De Taeye B; Verbeke K; Compernolle G; Biesemans W; Gils A; Declerck PJ
    Biochem Biophys Res Commun; 2003 Aug; 307(3):529-34. PubMed ID: 12893254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.
    Stoop AA; Eldering E; Dafforn TR; Read RJ; Pannekoek H
    J Mol Biol; 2001 Jan; 305(4):773-83. PubMed ID: 11162091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.
    Qureshi T; Goswami S; McClintock CS; Ramsey MT; Peterson CB
    Protein Sci; 2016 Feb; 25(2):499-510. PubMed ID: 26548921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
    Rodenburg KW; Kjoller L; Petersen HH; Andreasen PA
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of binding of the low density lipoprotein receptor-related protein to different conformational states of the clade E serpins plasminogen activator inhibitor-1 and proteinase nexin-1.
    Jensen JK; Dolmer K; Gettins PG
    J Biol Chem; 2009 Jul; 284(27):17989-97. PubMed ID: 19439404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of the highly conserved tryptophan in the serpin breach region alters the inhibitory mechanism of plasminogen activator inhibitor-1.
    Blouse GE; Perron MJ; Kvassman JO; Yunus S; Thompson JH; Betts RL; Lutter LC; Shore JD
    Biochemistry; 2003 Oct; 42(42):12260-72. PubMed ID: 14567688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of serpin reaction through stabilization of transient intermediate by ligands bound to alpha-helix F.
    Komissarov AA; Zhou A; Declerck PJ
    J Biol Chem; 2007 Sep; 282(36):26306-15. PubMed ID: 17613529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.
    Kjøller L; Martensen PM; Sottrup-Jensen L; Justesen J; Rodenburg KW; Andreasen PA
    Eur J Biochem; 1996 Oct; 241(1):38-46. PubMed ID: 8898886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maspin binds to urokinase-type and tissue-type plasminogen activator through exosite-exosite interactions.
    Al-Ayyoubi M; Schwartz BS; Gettins PG
    J Biol Chem; 2007 Jul; 282(27):19502-9. PubMed ID: 17510061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism.
    Shore JD; Day DE; Francis-Chmura AM; Verhamme I; Kvassman J; Lawrence DA; Ginsburg D
    J Biol Chem; 1995 Mar; 270(10):5395-8. PubMed ID: 7890653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.